1960 related articles for article (PubMed ID: 32505227)
1. Immunology of COVID-19: Current State of the Science.
Vabret N; Britton GJ; Gruber C; Hegde S; Kim J; Kuksin M; Levantovsky R; Malle L; Moreira A; Park MD; Pia L; Risson E; Saffern M; Salomé B; Esai Selvan M; Spindler MP; Tan J; van der Heide V; Gregory JK; Alexandropoulos K; Bhardwaj N; Brown BD; Greenbaum B; Gümüş ZH; Homann D; Horowitz A; Kamphorst AO; Curotto de Lafaille MA; Mehandru S; Merad M; Samstein RM;
Immunity; 2020 Jun; 52(6):910-941. PubMed ID: 32505227
[TBL] [Abstract][Full Text] [Related]
2. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
Chang FY; Chen HC; Chen PJ; Ho MS; Hsieh SL; Lin JC; Liu FT; Sytwu HK
J Biomed Sci; 2020 Jun; 27(1):72. PubMed ID: 32498686
[TBL] [Abstract][Full Text] [Related]
3. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI).
Sokolowska M; Lukasik ZM; Agache I; Akdis CA; Akdis D; Akdis M; Barcik W; Brough HA; Eiwegger T; Eljaszewicz A; Eyerich S; Feleszko W; Gomez-Casado C; Hoffmann-Sommergruber K; Janda J; Jiménez-Saiz R; Jutel M; Knol EF; Kortekaas Krohn I; Kothari A; Makowska J; Moniuszko M; Morita H; O'Mahony L; Nadeau K; Ozdemir C; Pali-Schöll I; Palomares O; Papaleo F; Prunicki M; Schmidt-Weber CB; Sediva A; Schwarze J; Shamji MH; Tramper-Stranders GA; van de Veen W; Untersmayr E
Allergy; 2020 Oct; 75(10):2445-2476. PubMed ID: 32584441
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment.
Prete M; Favoino E; Catacchio G; Racanelli V; Perosa F
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397684
[TBL] [Abstract][Full Text] [Related]
5. COVID-19: The Immune Responses and Clinical Therapy Candidates.
Zhand S; Saghaeian Jazi M; Mohammadi S; Tarighati Rasekhi R; Rostamian G; Kalani MR; Rostamian A; George J; Douglas MW
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756480
[TBL] [Abstract][Full Text] [Related]
6. Extrapulmonary manifestations of COVID-19.
Gupta A; Madhavan MV; Sehgal K; Nair N; Mahajan S; Sehrawat TS; Bikdeli B; Ahluwalia N; Ausiello JC; Wan EY; Freedberg DE; Kirtane AJ; Parikh SA; Maurer MS; Nordvig AS; Accili D; Bathon JM; Mohan S; Bauer KA; Leon MB; Krumholz HM; Uriel N; Mehra MR; Elkind MSV; Stone GW; Schwartz A; Ho DD; Bilezikian JP; Landry DW
Nat Med; 2020 Jul; 26(7):1017-1032. PubMed ID: 32651579
[TBL] [Abstract][Full Text] [Related]
7. The trinity of COVID-19: immunity, inflammation and intervention.
Tay MZ; Poh CM; Rénia L; MacAry PA; Ng LFP
Nat Rev Immunol; 2020 Jun; 20(6):363-374. PubMed ID: 32346093
[TBL] [Abstract][Full Text] [Related]
8. SnapShot: COVID-19.
Oberfeld B; Achanta A; Carpenter K; Chen P; Gilette NM; Langat P; Said JT; Schiff AE; Zhou AS; Barczak AK; Pillai S
Cell; 2020 May; 181(4):954-954.e1. PubMed ID: 32413300
[TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
Schijns V; Lavelle EC
Eur J Immunol; 2020 Jul; 50(7):932-938. PubMed ID: 32438473
[TBL] [Abstract][Full Text] [Related]
10. Severe COVID-19 disease and thromboinflammation.
Jerjes-Sánchez C
Arch Cardiol Mex; 2020; 90(3):257-258. PubMed ID: 32952161
[No Abstract] [Full Text] [Related]
11. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
Nowill AE; de Campos-Lima PO
J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687
[TBL] [Abstract][Full Text] [Related]
12. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.
Huizinga GP; Singer BH; Singer K
Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32880654
[TBL] [Abstract][Full Text] [Related]
13. Establishing a Unified COVID-19 "Immunome": Integrating Coronavirus Pathogenesis and Host Immunopathology.
Wauters E; Thevissen K; Wouters C; Bosisio FM; De Smet F; Gunst J; Humblet-Baron S; Lambrechts D; Liston A; Matthys P; Neyts J; Proost P; Weynand B; Wauters J; Tejpar S; Garg AD
Front Immunol; 2020; 11():1642. PubMed ID: 32719686
[No Abstract] [Full Text] [Related]
14. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
Amor S; Fernández Blanco L; Baker D
Clin Exp Immunol; 2020 Nov; 202(2):193-209. PubMed ID: 32978971
[TBL] [Abstract][Full Text] [Related]
15. The many faces of the anti-COVID immune response.
Vardhana SA; Wolchok JD
J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32353870
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.
Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP
FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736
[TBL] [Abstract][Full Text] [Related]
17. Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies.
Zhou T; Su TT; Mudianto T; Wang J
J Exp Med; 2020 Oct; 217(10):. PubMed ID: 32910820
[TBL] [Abstract][Full Text] [Related]
18. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.
Kumar V
Int Immunopharmacol; 2020 Nov; 88():106980. PubMed ID: 33182073
[TBL] [Abstract][Full Text] [Related]
19. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.
Netea MG; Giamarellos-Bourboulis EJ; Domínguez-Andrés J; Curtis N; van Crevel R; van de Veerdonk FL; Bonten M
Cell; 2020 May; 181(5):969-977. PubMed ID: 32437659
[TBL] [Abstract][Full Text] [Related]
20. Early Insights into Immune Responses during COVID-19.
St John AL; Rathore APS
J Immunol; 2020 Aug; 205(3):555-564. PubMed ID: 32513850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
